CAMBRIDGE, Mass. and DENVER, April 8, 2024 /PRNewswire/ — Kytopen Corp., a leader in the development of manufacturing platforms and workflows for advanced therapeutic medicines, today announced the appointment of Kevin Gutshall as Chief Commercial Officer, effective April 1st, 2024. Mr….



Leave a Reply

Your email address will not be published. Required fields are marked *